Jonathan Miner MD, PhD, joins the Division of Infectious Diseases

Jonathan Miner MD, PhD, completed his residency in internal medicine and a fellowship in rheumatology at Washington University School of Medicine. (WUSM) He completed a postdoctoral fellowship in Mike Diamond’s lab and became faculty in the Department of Medicine, Rheuematology in 2016. Dr. Miner is an extremely accomplished physician-scientist whose laboratory studies the intersection of […]

Sharmila Nair, PhD, joins the Division of Infectious Diseases

Sharmila Nair, PhD, joined the Department of Medicine in the Division of Infectious Diseases as an Instructor in July, 2020. Dr. Nair grew up in India completed her Bachelor’s degree at the Amity University, India. She was interested in infectious diseases, especially dengue at that time, and moved to England to pursue her Masters by […]

Journal of Infectious Diseases publishes supplement 2020 Inclusion, Diversity, Access and Equity in Infectious Diseases: Nurturing the Next Generation of Clinicians, Scientists and Leaders

A new collection of articles, now available online, highlights the critical importance of nurturing a diverse next generation of infectious diseases specialists and leaders. Published as an IDSA-sponsored supplement to The Journal of Infectious Diseases, the articles build on a 2019 supplement, part of an ongoing effort to improve inclusion, diversity, access, and equity within IDSA and the […]

Independent scientists are calling on drugmakers to be more transparent about COVID-19 clinical trials and safety concerns. Mati Hlatshwayo Davis, MD, MPH joins several media outlets to discuss facts over fear.

Dr. Hlatshwayo Davis, ID fellow alumna ’18 and instructor of medicine, speaks to NBC News Now about COVID-19 vaccine transparency , the rising numbers in the Midwest and indoor dining during the pandemiic. Mati Hlatshwayo Davis, MD, MPH was recently featured in several media channels speaking on COVID-19, community engagement and advocacy for marginalized communities. […]

Novel clinical trial launched to test multiple therapeutics to treat COVID-19

The Infectious Disease Clinical Research Unit at Washington University School of Medicine has launched the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the AIDS Clinical Trials Group. The school’s Infectious Disease Clinical Research Unit is one of 25 initial sites conducting ACTIV-2, which includes both phase 2 and phase […]

Baldridge receives prestigious award as Investigator in the Pathogenesis of Infectious Diseases by the Burroughs Wellcome Fund

Megan Baldridge, MD, PhD, an assistant professor of medicine at Washington University School of Medicine in St. Louis, has been named an Investigator in the Pathogenesis of Infectious Diseases by the Burroughs Wellcome Fund. Each awardee receives $500,000 over five years to support research projects that hold the potential to significantly advance understanding of how […]

Matifadza Hlatshwayo Davis, M.D., MPH, shares her opinion with Newsweek “Rushing a COVID-19 Vaccine Risks Leaving Behind the People Most at Risk”

Matifadza Hlatshwayo Davis, MD, MPH, ID alumae ’18, is a clinical instructor in infectious diseases at Washington University School of Medicine and the John Cochran VA Medical Center in St. Louis, as well as an infectious diseases physician and researcher.  Dr. Davis discusses how there are alarmingly few vaccine volunteers from the communities who have […]

WUSM ID Fellows, Miguel Chavez and Nathanial Nolan, launch ID Fellows Network on Twitter (#ID_fellows), an educational space for fellows by fellows

Inspired by all the fantastic #MedEd content provided by #IDtwitter community, several fellows have joined resources to create the ID Fellows Network (#ID_fellows), an educational space for fellows by fellows.This is a collaborative approach to promote ID clinical reasoning for fellows.  In just under 2 months they have over 2,400 Followers. They share tweetorials, clinical […]

Gerome Escota, MD, honored with “Sidney S. Pearl, MD, ’32 Clinical Teacher of the Year”

In 1979, Sidney S. Pearl, MD, alumnus of the class of 1932, established an award for inspirational teaching to be chosen by the medical school graduating class, from among the clinical faculty. The award was presented to Dr. Escota at the MD Commencement Recognition Ceremony 2020 by Dr. Brian Hickman, medical education representative and member […]

IDSA honors Rachel Presti, MD, PhD, among distinguished physicians, scientists with FIDSA Designation

The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA. This year, Rachel M. Presti, MD, PhD, Associate Professor of Medicine, Infectious Diseases Division,  was honored with […]

Join us on Sept. 24, 2020 for a CME event: Telemedicine in Infectious Diseases during a Pandemic

The ID Society  of St. Louis, in partnership with the Washington University Infectious Diseases Division and joint providership with the St. Louis STD/HIV Prevention Training Center,  is proud to host a CME-Accredited education opportunity on Telemedicine. We are fortunate to have as our guest speaker, St. Louis native, Javeed Siddiqui, MD, MPH, co-founder and chief […]

Spec selected Deputy Editor of Mycoses

Andrej Spec, MD, MSCI, assistant has accepted the role as deputy editor of Mycoses. Dr. Spec is also an associate editor for Open Forum Infectious Diseases (OFID), and serves on the editorial boards of Medical Mycology and Clinical Infectious Diseases (CID).

Podcast: Where does life in the U.S. stand six months into the pandemic?

This episode of ‘Show Me the Science’ looks at where the nation has come and where we may be headed as coronavirus infections and deaths continue to rise. A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington […]

Washington University develops COVID-19 saliva test

Test is faster, simpler than nasal, oral swab tests and enables screening on a massive scale A new saliva test to detect the SARS-CoV-2 virus has been developed by researchers at Washington University School of Medicine in St. Louis. Results from the COVID-19 diagnostic test are available in a few hours and, ideally, able to […]

Washington University, St. Louis County collaborate on COVID-19 survey

Washington University in St. Louis, the St. Louis County Department of Public Health and other collaborators are conducting a survey of St. Louis County residents and offering COVID-19 testing to gauge the prevalence of and risk factors for the illness. Working with the county, Washington University’s Institute for Public Health is teaming up with other local public health and […]

Meet our ID Fellowship Program Leaders

The Infectious Diseases Division introduces the leaders of the Infectious Diseases Fellowship Program. Gerome Escota, MD has been named co-director of the ID Fellowship Program. Dr. Escota has been involved in the fellowship program as associate director. He completed his medicine degree at the College of Medicine, University of the Philippines in 2004, and ID […]

Rachel Presti, MD, PhD leads Washington University effort to conduct COVID-19 vaccine trials in collaboration with Saint Louis University

As U.S. scientists ramp up a national effort to evaluate COVID-19 vaccine candidates at clinical trial sites across the country, researchers at Washington University School of Medicine in St. Louis and the Saint Louis University Center for Vaccine Development have been tapped to join the historic effort to find a COVID-19 vaccine that can prevent […]

WUSM scientists create a safer version of virus to speed research

The virus that causes COVID-19 is so dangerous that scientists studying it must wear full-body biohazard suits with pressurized respirators inside high-level biosafety labs. But scientists at Washington University School of Medicine have developed a defanged virus that acts like SARS-CoV-2, but that can be handled under ordinary lab safety conditions, according to a study […]